Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06919042 · ClinicalTrials.gov registry record · NA
Shockwave in Postoperative Breast Reconstruction Fibrosis
A NA study of Fibrosis Breast, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06919042: Recruiting NA study of Fibrosis Breast, sponsored by Northwestern University.
NCT06919042 is a NA study of Fibrosis Breast that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06919042, a NA study of Fibrosis Breast, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.
Primary Outcome
Change in size of subcutaneous fibrosis mass assess clinically by PI, point-of-care ultrasound, caliper measurements, and objective/subjective measures by an observer and the patient. Score values range from 1 to 10 with a higher score indicating a worse outcome.
Conditions Studied
Interventions
- DEVICE Pulsed Acoustic Cellular Expression therapy
Study Locations (1)
Illinois
- Lavin Pavilion Suite 2060 - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT06919042 shows while recruiting
NCT06919042 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Fibrosis Breast appearing as the primary indexed condition, and to 1 intervention - of which Pulsed Acoustic Cellular Expression therapy is the first listed.
NCT06919042 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06919042 about?
NCT06919042 is a clinical study titled "Shockwave in Postoperative Breast Reconstruction Fibrosis". This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.
What is the current status of trial NCT06919042?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-01. Estimated completion is 2026-09.
What conditions does trial NCT06919042 study?
This clinical trial studies the following conditions: Fibrosis Breast.
What interventions are being tested in trial NCT06919042?
The interventions under investigation include: Pulsed Acoustic Cellular Expression therapy (DEVICE).
Who is sponsoring clinical trial NCT06919042?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06919042 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06919042's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI